| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 759216 | (3-(4-bromophenyl)-5-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydropyrazol-1-yl)(4-methoxyphenyl)methanone | 0.0339770934764508 | -0.076900776 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0339770934764508 | 0.38141215 |
| NSC 88054 | Null | 0.0339770934764508 | 0.36500293 |
| NSC 285233 | Null | 0.0339770934764511 | 0.3192581 |
| NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 0.0339770934764516 | 0.4007097 |
| NSC 149286 | 1,4-Pentadien-3-one, 1,5-di-3-pyridyl- | 0.0339770934764516 | 0.58895302 |
| NSC 169774 | Bromocriptine methanesulfonate | 0.0339770934764516 | 0.58173596 |
| NSC 20200 | [Diisobutyl(phenoxyethoxy)ethyl]dimethylbenzylammonium chloride | 0.0339770934764516 | 0.32679914 |
| NSC 205555 | Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- | 0.0339770934764516 | 0.36423044 |
| NSC 274539 | Olivomycin D, 3B-O-(2,6-dideoxy-3-C-methyl-L-arabinohexopyranosyl)- | 0.0339770934764516 | 0.13768222 |